应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。
关闭
CINC CinCor Pharma, Inc.
停牌 02-23 16:00:00 EST
29.06
+0.00
0.00%
最高
29.06
最低
29.06
成交量
0.00
今开
29.06
昨收
29.06
日振幅
0.00%
总市值
12.72亿
流通市值
5.20亿
总股本
4,376万
成交额
1.85亿
换手率
0.00%
流通股本
1,791万
市净率
2.45
ROE
-26.91%
每股收益
-3.09
52周最高
43.15
52周最低
10.53
市盈率
-9.39
股息
0.00
股息收益率
0.00
ROA
-15.25%
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
暂无数据
公司概况
公司名称：
CinCor Pharma, Inc.
所属市场：
NASDAQ
上市日期：
2022-01-07
主营业务：
CinCor Pharma, Inc.于2018年3月根据特拉华州法律注册成立。该公司是一家临床阶段的生物制药公司，专注于开发其主要临床候选药物CIN-107，用于治疗高血压和其他心肾疾病。CIN-107是一种高度选择性的口服小分子醛固酮合酶抑制剂，该酶负责在肾上腺中合成醛固酮。CIN-107旨在使用不同的作用机制，直接抑制醛固酮合酶的产生，目的是为患有高血压的患者提供更好的治疗。该公司正在评估CIN-107作为一种潜在治疗方法的疗效和安全性，适用于广泛的高血压人群，包括治疗后仍未达到血压控制的不同高血压患者亚群。除了高血压，该公司正在开发CIN-107用于治疗原发性醛固酮增多症或PA，并探索其在改善慢性肾病或CKD并发症方面的效用。
发行价格：
16.00
{"stockData":{"symbol":"CINC","market":"US","secType":"STK","nameCN":"CinCor Pharma, Inc.","latestPrice":29.06,"timestamp":1677186000000,"preClose":29.06,"halted":3,"volume":0,"delay":0,"floatShares":17907502,"shares":43764193,"eps":-3.093661,"marketStatus":"停牌","change":0,"latestTime":"02-23 16:00:00 EST","open":29.06,"high":29.06,"low":29.06,"amount":184780696.683,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-3.093661,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1746432000000},"marketStatusCode":7,"adr":0,"listingDate":1641531600000,"exchange":"NASDAQ","adjPreClose":29.06,"volumeRatio":0},"requestUrl":"/m/hq/s/CINC","defaultTab":"news","newsList":[],"profile":{"websiteUrl":"http://www.cincor.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0},{"period":"1year","weight":0},{"period":"ytd","weight":0}],"compareEarnings":[{"period":"1week","weight":0.0293},{"period":"1month","weight":0.004},{"period":"3month","weight":-0.0583},{"period":"6month","weight":-0.0075},{"period":"1year","weight":0.1222},{"period":"ytd","weight":-0.033}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"CinCor Pharma, Inc.于2018年3月根据特拉华州法律注册成立。该公司是一家临床阶段的生物制药公司，专注于开发其主要临床候选药物CIN-107，用于治疗高血压和其他心肾疾病。CIN-107是一种高度选择性的口服小分子醛固酮合酶抑制剂，该酶负责在肾上腺中合成醛固酮。CIN-107旨在使用不同的作用机制，直接抑制醛固酮合酶的产生，目的是为患有高血压的患者提供更好的治疗。该公司正在评估CIN-107作为一种潜在治疗方法的疗效和安全性，适用于广泛的高血压人群，包括治疗后仍未达到血压控制的不同高血压患者亚群。除了高血压，该公司正在开发CIN-107用于治疗原发性醛固酮增多症或PA，并探索其在改善慢性肾病或CKD并发症方面的效用。","exchange":"NASDAQ","name":"CinCor Pharma, Inc.","nameEN":"CinCor Pharma, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.33.2","shortVersion":"4.33.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"CinCor Pharma, Inc.(CINC)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供CinCor Pharma, Inc.(CINC)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"CinCor Pharma, Inc.,CINC,CinCor Pharma, Inc.股票,CinCor Pharma, Inc.股票老虎,CinCor Pharma, Inc.股票老虎国际,CinCor Pharma, Inc.行情,CinCor Pharma, Inc.股票行情,CinCor Pharma, Inc.股价,CinCor Pharma, Inc.股市,CinCor Pharma, Inc.股票价格,CinCor Pharma, Inc.股票交易,CinCor Pharma, Inc.股票购买,CinCor Pharma, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"CinCor Pharma, Inc.(CINC)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供CinCor Pharma, Inc.(CINC)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}